Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
340
Price
$586.73
Total Value
$199.49K
Shares Held After
20,176
% of Holdings
1.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
640
Price
$585.83
Total Value
$374.93K
Shares Held After
20,516
% of Holdings
3.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
400
Price
$584.21
Total Value
$233.68K
Shares Held After
21,156
% of Holdings
1.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
200
Price
$583.41
Total Value
$116.68K
Shares Held After
21,556
% of Holdings
0.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
281
Price
$581.50
Total Value
$163.40K
Shares Held After
21,756
% of Holdings
1.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
399
Price
$580.37
Total Value
$231.57K
Shares Held After
22,037
% of Holdings
1.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
520
Price
$578.65
Total Value
$300.90K
Shares Held After
22,436
% of Holdings
2.3%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
640
Price
$577.42
Total Value
$369.55K
Shares Held After
22,956
% of Holdings
2.7%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
1,002
Price
$575.98
Total Value
$577.13K
Shares Held After
23,596
% of Holdings
4.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
1,045
Price
$575.14
Total Value
$601.02K
Shares Held After
24,598
% of Holdings
4.1%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
1,306
Price
$573.94
Total Value
$749.57K
Shares Held After
25,643
% of Holdings
4.8%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
807
Price
$572.93
Total Value
$462.35K
Shares Held After
26,949
% of Holdings
2.9%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
560
Price
$571.77
Total Value
$320.19K
Shares Held After
27,756
% of Holdings
2.0%

UNITED THERAPEUTICS Corp (UTHR)

EDGEMOND JAMES — CFO AND TREASURER
May 7, 2026
Sale
Shares
560
Price
$569.71
Total Value
$319.04K
Shares Held After
28,316
% of Holdings
1.9%

EXELIXIS, INC. (EXEL)

POSTE GEORGE — Director
May 7, 2026
Sale
Shares
60,000
Price
$45.71
Total Value
$2.74M
Shares Held After
118,832
% of Holdings
33.6%

EXELIXIS, INC. (EXEL)

Beckerle Mary C — Director
May 7, 2026
Sale
Shares
7,712
Price
$48.45
Total Value
$373.65K
Shares Held After
17,524
% of Holdings
30.6%

EXELIXIS, INC. (EXEL)

Freire Maria C — Director
May 7, 2026
Sale
Shares
20,634
Price
$46.00
Total Value
$949.16K
Shares Held After
100,819
% of Holdings
17.0%
May 7, 2026
Sale
Shares
9,000
Price
$26.06
Total Value
$234.54K
Shares Held After
19,839
% of Holdings
31.2%

Axogen, Inc. (AXGN)

JOHNSON JOHN — Director
May 7, 2026
Sale
Shares
11,050
Price
$43.26
Total Value
$477.97K
Shares Held After
0
% of Holdings
100.0%

Axogen, Inc. (AXGN)

Kemp Jens — Chief Marketing Officer
May 7, 2026
Sale
Shares
4,000
Price
$43.44
Total Value
$173.76K
Shares Held After
72,451
% of Holdings
5.2%
May 7, 2026
Sale
Shares
16,344
Price
$44.09
Total Value
$720.62K
Shares Held After
0
% of Holdings
100.0%
May 7, 2026
Sale
Shares
45,456
Price
$55.05
Total Value
$2.50M
Shares Held After
35,470
% of Holdings
56.2%

Vericel Corp (VCEL)

SIEGAL JONATHAN — Principal Accounting Officer
May 7, 2026
Sale
Shares
1,422
Price
$40.50
Total Value
$57.59K
Shares Held After
1,118
% of Holdings
56.0%

Vericel Corp (VCEL)

Mara Joseph Anthony Jr — Chief Financial Officer
May 7, 2026
Sale
Shares
5,000
Price
$40.50
Total Value
$202.50K
Shares Held After
21,009
% of Holdings
19.2%
May 7, 2026
Sale
Shares
573
Price
$43.67
Total Value
$25.02K
Shares Held After
65,146
% of Holdings
0.9%
May 7, 2026
Sale
Shares
478
Price
$43.67
Total Value
$20.87K
Shares Held After
62,756
% of Holdings
0.8%

Axogen, Inc. (AXGN)

Quackenbush Doris — Sales VP
May 7, 2026
Sale
Shares
3,878
Price
$43.51
Total Value
$168.72K
Shares Held After
92,416
% of Holdings
4.0%

InspireMD, Inc. (NSPR)

Stuka Paul — Director
May 7, 2026
Purchase
Shares
6,378
Price
$1.15
Total Value
$7.33K
Shares Held After
531,599
% of Holdings
1.2%

InspireMD, Inc. (NSPR)

ROUBIN GARY S — Director
May 7, 2026
Purchase
Shares
90,000
Price
$1.18
Total Value
$106.20K
Shares Held After
834,478
% of Holdings
10.8%

InspireMD, Inc. (NSPR)

Ward Scott R. — Director
May 7, 2026
Purchase
Shares
73,255
Price
$1.15
Total Value
$84.24K
Shares Held After
237,096
% of Holdings
30.9%
May 7, 2026
Sale
Shares
12,819
Price
$8.20
Total Value
$105.17K
Shares Held After
5,124,740
% of Holdings
0.2%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 7, 2026
Sale
Shares
9
Price
$155.25
Total Value
$1.40K
Shares Held After
0
% of Holdings
100.0%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 7, 2026
Sale
Shares
3
Price
$154.61
Total Value
$463.83
Shares Held After
9
% of Holdings
25.0%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 7, 2026
Sale
Shares
428
Price
$153.56
Total Value
$65.73K
Shares Held After
12
% of Holdings
97.3%

BELITE BIO, INC (BLTE)

MATA NATHAN L. — Chief Scientific Officer
May 7, 2026
Sale
Shares
226
Price
$152.45
Total Value
$34.45K
Shares Held After
440
% of Holdings
33.9%
May 7, 2026
Sale
Shares
40,000
Price
$3.37
Total Value
$134.80K
Shares Held After
926,556
% of Holdings
4.1%
May 7, 2026
Purchase
Shares
5,000
Price
$12.26
Total Value
$61.30K
Shares Held After
90,809
% of Holdings
5.5%

APTARGROUP, INC. (ATR)

Hudson Irene Elizabeth — EVP and Chief Legal Officer
May 7, 2026
Sale
Shares
842
Price
$123.45
Total Value
$103.95K
Shares Held After
1,480
% of Holdings
36.3%

APTARGROUP, INC. (ATR)

Hudson Irene Elizabeth — EVP and Chief Legal Officer
May 7, 2026
Sale
Shares
422
Price
$123.38
Total Value
$52.07K
Shares Held After
1,480
% of Holdings
22.2%
May 7, 2026
Sale
Shares
2,029
Price
$49.19
Total Value
$99.82K
Shares Held After
56,152
% of Holdings
3.5%
May 7, 2026
Sale
Shares
1,149
Price
$48.31
Total Value
$55.51K
Shares Held After
58,181
% of Holdings
1.9%
May 7, 2026
Sale
Shares
1,350
Price
$47.59
Total Value
$64.25K
Shares Held After
59,330
% of Holdings
2.2%
May 7, 2026
Purchase
Shares
904
Price
$12.15
Total Value
$10.98K
Shares Held After
382,450
% of Holdings
0.2%
May 7, 2026
Purchase
Shares
1,808
Price
$12.20
Total Value
$22.05K
Shares Held After
381,546
% of Holdings
0.5%
May 7, 2026
Purchase
Shares
9,096
Price
$12.15
Total Value
$110.49K
Shares Held After
3,848,573
% of Holdings
0.2%
May 7, 2026
Purchase
Shares
18,192
Price
$12.20
Total Value
$221.90K
Shares Held After
3,839,477
% of Holdings
0.5%

Liquidia Corp (LQDA)

JEFFS ROGER — Director
May 7, 2026
Sale
Shares
25,000
Price
$42.09
Total Value
$1.05M
Shares Held After
1,348,095
% of Holdings
1.8%
May 7, 2026
Sale
Shares
79,086
Price
$0.63
Total Value
$49.82K
Shares Held After
1,578,749
% of Holdings
4.8%
May 7, 2026
Purchase
Shares
24,154
Price
$20.69
Total Value
$499.67K
Shares Held After
73,383
% of Holdings
32.9%

UNITED THERAPEUTICS Corp (UTHR)

MAHON PAUL A — EVP & GENERAL COUNSEL
May 7, 2026
Sale
Shares
202
Price
$597.54
Total Value
$120.70K
Shares Held After
45,172
% of Holdings
0.4%
Version: v26.5.2